10913
Quantifying The Improved Treatment Effect Of Lecanemab And Donanemab In Minority Populations With Comorbidities
Suzanne Hendrix
Poster Presenter: Suzanne Hendrix
Alzheimer's Association International Conference 2026
July 12-15, 2026 | London, United Kingdom, and Online
Authors
Showing 5 results for author "Suzanne Hendrix".
10948
Optimizing Pre-symptomatic Alzheimer’S Trials: A Power Comparison Of Continuous Endpoints Vs. Time-to-event Analysis
Caleb Dayley, Samuel Dickson, Suzanne Hendrix, Jason Cook, Kent Hendrix, Craig Mallinckrodt
Pentara Corporation
Poster Presenter: Caleb Dayley
13738
Continued Or Time-limited Treatment Benefits Of Anti-amyloid Monoclonal Antibodies In Early Alzheimer’S Disease
Suzanne Hendrix
Poster Presenter: Suzanne Hendrix
6663
Retrospective Analysis Of Costs Of Amyloid Diagnostic Tests For Alzheimer’s Disease From A Health-System Perspective
Suzanne Hendrix, Feride Frech, Courtney Adams, Laura Schott, Sunday Ipke, Daryl Jones, Soeren Mattke
null,
Poster Presenter: Feride Frech
9889
Estimating The Economic Impact Of Delayed Alzheimers Disease Progression With Lecanemab
Suzanne Hendrix, Sam Dickson, Chenyue Zhao, Katherine Youmans-Kidder, Feride Frech, Dean Smith
null,
Poster Presenter: Suzanne Hendrix